🔎 Trials Near Me

Gara Jalqabaatti › Lymphoma Selii Mantle › New York › New York City

Qorannoo klinikaalii Lymphoma Selii Mantle New York City, NY keessatti

Qorannoo 12 Lymphoma Selii Mantle f New York City fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies

Namoota walitti qabaa jiraSadarkaa 1/2
  • Columbia University Medical Center, New York
  • Weill Cornell Medical College Newyork Presbyterian Hospital, New York
  • Memorial Sloan Kettering Cancer Center Mskcc, New York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT05006716

Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma

Namoota walitti qabaa jiraSadarkaa 3
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
  • NYP/Weill Cornell Medical Center, New York
Umuriin 60 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT05976763

A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.

Namoota walitti qabaa jiraSadarkaa 1/2
  • Research Site, New York
  • Research Site, New York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT06542250

A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)

Namoota walitti qabaa jiraSadarkaa 3
  • Memorial Sloan Kettering Cancer Center Mskcc, New York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT06742996

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

Namoota walitti qabaa jiraSadarkaa 1
  • New York University (NYU) Clinical Cancer Center, New York
  • Weill Cornell Medicine, New York
  • David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07101328

A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies

Namoota walitti qabaa jiraSadarkaa 1/2
  • Research Site, New York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 08-Ful-2026 · NCT06564038

A Study of ARC-02 in B-cell NHL

Namoota walitti qabaa jiraSadarkaa 1
  • NYU Langone, New York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 26-Hag-2026 · NCT07691606

This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma

Namoota walitti qabaa jiraSadarkaa 1
  • Memorial Sloan Kettering Cancer Center - Bergen, New York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Ado-2026 · NCT07121946

DALY II USA/ MB-CART2019.1 for DLBCL

Namoota walitti qabaa jiraSadarkaa 2
  • Memorial Sloan Kettering Cancer Center, New York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 13-Ado-2026 · NCT04792489

BRAZAN: A Randomized Phase 2 Study of Bendamustine, Rituximab, Cytarabine (AraC) Induction With Zanubrutinib (BRAZAN) Followed by Zanubrutinib/Rituximab +/- Sonrotoclax Maintenance in Treatment-Naïve Mantle Cell Lymphoma

Namoota walitti qabaa jiraSadarkaa 2
  • Memorial Sloan Kettering Cancer Center, New York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 20-Gur-2026 · NCT06854003

Study of SGR-1505 in Mature B-Cell Neoplasms

Namoota walitti qabaa jiraSadarkaa 1
  • Weill Cornell, New York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 13-Gur-2026 · NCT05544019

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Massive Bio SYNERGY-AI site, New York
Umuriin hundi · Saalaa hunda · Haaromfame 28-Onk-2025 · NCT03452774

Qorannoo Lymphoma Selii Mantle magaalota biroo keessatti

Qorannoo biroo New York City keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.